Nerve growth factor induced phosphatidylinositol turnover effect of 6-hydroxydopamine treatment.
D000818:Animals; D000831:Animals, Newborn; D005725:Ganglia, Autonomic / Q000187:drug effects* / Q000378:metabolism; D006892:Hydroxydopamines / Q000494:pharmacology*; D009414:Nerve Growth Factors / Q000494:pharmacology*; D010716:Phosphatidylinositols / Q000378:metabolism*; D010870:Pineal Gland / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects
D006892:Hydroxydopamines; D009414:Nerve Growth Factors; D010716:Phosphatidylinositols; D011955:Receptors, Drug